Hepatitis E virus (HEV) genotype 4 (HEV-4) is an emerging cause of acute hepatitis in China. Less is known about the clinical characteristics and natural history of HEV-4 than HEV genotype 3 infections in immunocompromised patients. We report transmission of HEV-4 from a deceased organ donor to 5 transplant recipients. The donor had been viremic but HEV IgM and IgG seronegative, and liver function test results were within reference ranges. After a mean of 52 days after transplantation, hepatitis developed in all 5 recipients; in the liver graft recipient, disease was severe and with progressive portal hypertension. Despite reduced immunosuppression, all HEV-4 infections progressed to persistent hepatitis. Four patients received ribavirin and showed evidence of response after 2 months. This study highlights the role of organ donation in HEV transmission, provides additional data on the natural history of HEV-4 infection, and points out differences between genotype 3 and 4 infections in immunocompromised patients.
CITATION STYLE
Sridhar, S., Cheng, V. C. C., Wong, S. C., Yip, C. C. Y., Wu, S., Lo, A. W. I., … Yuen, K. Y. (2019). Donor-derived genotype 4 hepatitis E virus infection, Hong Kong, China, 2018. Emerging Infectious Diseases, 25(3), 425–433. https://doi.org/10.3201/eid2503.181563
Mendeley helps you to discover research relevant for your work.